These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 4007783)

  • 1. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatment of hyperthyroidism during pregnancy.
    Cassina M; Donà M; Di Gianantonio E; Clementi M
    Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):612-9. PubMed ID: 22511519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose.
    Cooper DS; Goldminz D; Levin AA; Ladenson PW; Daniels GH; Molitch ME; Ridgway EC
    Ann Intern Med; 1983 Jan; 98(1):26-9. PubMed ID: 6687345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis.
    Cheung CL; Sing CW; Tang CS; Cheng VK; Pirmohamed M; Choi CH; Hung CS; Lau EY; Lee KF; Mak MW; Leung JY; Wong TW; Ho AY; Chan KW; Hung V; Tam V; Siu SC; Pang HK; Wat WZ; Lee HH; Chung CT; Hue RS; Sham PC; Cheung BM; Wong IC; Tan KC; Kung A
    Clin Pharmacol Ther; 2016 May; 99(5):555-61. PubMed ID: 26599303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
    Rivkees SA; Szarfman A
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3260-7. PubMed ID: 20427502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent agranulocytosis induced by two different antithyroid agents.
    Chen B; Lang R; Jutrin Y; Ravid M
    Med J Aust; 1983 Jul; 2(1):38-9. PubMed ID: 6865827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil.
    Diav-Citrin O; Ornoy A
    Teratology; 2002 Jan; 65(1):38-44. PubMed ID: 11835230
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent agranulocytosis following carbimazole and propylthiouracil therapy.
    Ostlere S; Apthorp GH
    Br J Clin Pract; 1988 Nov; 42(11):474-5. PubMed ID: 3256337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agranulocytosis and antithyroid drugs.
    Rosove MH
    West J Med; 1977 May; 126(5):339-43. PubMed ID: 867981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.
    Rivkees SA
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4332-5. PubMed ID: 24194618
    [No Abstract]   [Full Text] [Related]  

  • 13. Methimazole-induced hepatotoxicity.
    Woeber KA
    Endocr Pract; 2002; 8(3):222-4. PubMed ID: 12467281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
    Jain K; Chakrapani M; Smitha K
    Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.
    Chang LC; Chang CC; Chen PL; Wang SH; Chen YH; Tsai YH; Shih SR; Chiu WY; Fann CS; Yang WS; Chang TC
    Expert Opin Drug Saf; 2018 Aug; 17(8):775-784. PubMed ID: 30067105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Yoshimura Noh J; Inoue K; Suzuki N; Yoshihara A; Fukushita M; Matsumoto M; Imai H; Hiruma S; Ichikawa M; Koshibu M; Sankoda A; Hirose R; Watanabe N; Sugino K; Ito K
    Endocr J; 2024 Jul; 71(7):695-703. PubMed ID: 38710619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
    Pearce SH
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):589-94. PubMed ID: 15521961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.